Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of the Electromagnetic Field (EMF) Radiation on Transcriptomic Profile of Pig Myometrium during the Peri-Implantation Period-An In Vitro Study. | Int J Mol Sci | 2021 | 34298942 | PubTator, text mining | PubMed |
| Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma. | Thorac Cancer | 2021 | 34297484 | PubTator, text mining | PubMed |
| Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma. | Front Oncol | 2021 | 34277444 | PubTator, text mining | PubMed |
| Long Non-Coding RNA GABPB1-AS1 Augments Malignancy of Glioma Cells by Sequestering MicroRNA-330 and Reinforcing the ZNF367/Cell Cycle Signaling Pathway. | Neuropsychiatr Dis Treat | 2021 | 34276213 | PubTator, text mining | PubMed |
| Oncogenic role of ALX3 in cervical cancer cells through KDM2B-mediated histone demethylation of CDC25A. | BMC Cancer | 2021 | 34266408 | PubTator, text mining | PubMed |
| The Replication Stress Response on a Narrow Path Between Genomic Instability and Inflammation. | Front Cell Dev Biol | 2021 | 34249949 | PubTator, text mining | PubMed |
| Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer. | Pharmaceuticals (Basel) | 2021 | 34207383 | PubTator, text mining | PubMed |
| Targeting CDK9 for the Treatment of Glioblastoma. | Cancers (Basel) | 2021 | 34207158 | PubTator, text mining | PubMed |
| Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications. | Cancers (Basel) | 2021 | 34204886 | PubTator, text mining | PubMed |
| Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation. | Int J Mol Sci | 2021 | 34199160 | PubTator, text mining | PubMed |
| Replication catastrophe induced by cyclic hypoxia leads to increased APOBEC3B activity. | Nucleic Acids Res | 2021 | 34197599 | PubTator, text mining | PubMed |
| Systemic Analysis of the DNA Replication Regulator MCM Complex in Ovarian Cancer and Its Prognostic Value. | Front Oncol | 2021 | 34178669 | PubTator, text mining | PubMed |
| Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer. | BMC Cancer | 2021 | 34174849 | PubTator, text mining | PubMed |
| The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance. | Cancer Cell | 2021 | 34171263 | PubTator, text mining | PubMed |
| Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer. | Mol Oncol | 2021 | 34137158 | PubTator, text mining | PubMed |
| Frame-shift mediated reduction of gain-of-function p53 R273H and deletion of the R273H C-terminus in breast cancer cells result in replication-stress sensitivity. | Oncotarget | 2021 | 34136083 | PubTator, text mining | PubMed |
| PrimPol-mediated repriming facilitates replication traverse of DNA interstrand crosslinks. | EMBO J | 2021 | 34128550 | PubTator, text mining | PubMed |
| Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening. | Cancer Discov | 2021 | 34127480 | PubTator, text mining | PubMed |
| High FAM189B Expression and Its Prognostic Value in Patients with Gastric Cancer. | Biomed Res Int | 2021 | 34124264 | PubTator, text mining | PubMed |
| SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma. | BMC Cancer | 2021 | 34116656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=23